• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·RJH.BK
Share

Rajthanee Hospital Public Company Limited Stocks

THB 15.9Last Updated 03.11.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

THB 141.65M

THB 15.9
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rajthanee Hospital Public Company Limited, along with its affiliated businesses, delivers a comprehensive array of medical services across Thailand. The company provides various healthcare offerings, including general treatment, wellness improvement, rehabilitation, and disease prevention, catering to both common and severe illnesses through its team of general and specialized medical professionals. Its extensive departmental coverage includes internal medicine, surgical procedures and orthopedics, pediatric care, obstetrics and gynecology, ear, nose, and throat (ENT), eye care, anesthesia, diagnostic imaging, and dentistry. Additionally, Rajthanee Hospital manages specialized units such as emergency and brain neurosurgery, cardiology, surgery, orthopedics, preventive health check-ups, radiology, general diagnostics, ophthalmology, hemodialysis, sleep disorder testing, and dental centers. Established in 1990, the company's principal office is located in Phra Nakhon Si Ayutthaya, Thailand.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of RJH.BK is 15.5 and suggests 2.52% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.11.2026 02:14

The Dow soared 3% following the Democrats' election victory: this is its best gain in 1.5 years

05.11.2026 01:29

Five tech giants gain $750 bln post-midterms. JPMorgan sees the rally broadening.

05.11.2026 00:54

Shares of defense companies fell following the Democrats' success in the U.S. What happens next?

05.11.2026 00:02

Brent crude falls 10% as Democratic sweep raises hopes for end to Iran war

04.11.2026 23:06

"In the Spotlight": Why Tesla and SpaceX Stocks Are Falling Despite the Market's Uptrend

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026